stage IVA cervical cancer
Showing 26 - 50 of >10,000
Cervical Cancer, Stage IB Cervical Cancer, Stage IIA Cervical Cancer Trial (proton beam radiation therapy, radiation therapy
Withdrawn
- Cervical Cancer
- +5 more
- proton beam radiation therapy
- +2 more
- (no location specified)
Apr 2, 2020
Radiomics-based Malnutrition for Cervical Cancer.
Not yet recruiting
- Cervical Cancer
- Malnutrition
- There are no interventions.
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Jan 24, 2023
Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- without concurrent cisplatin chemotherapy
- with concurrent cisplatin chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 18, 2023
Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma Trial in
Recruiting
- Advanced Vaginal Adenocarcinoma
- +20 more
- Brachytherapy
- +6 more
-
Birmingham, Alabama
- +383 more
Aug 18, 2022
Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)
Not yet recruiting
- Cervical Cancer
- Anti-PD-1 antibody balstilimab
-
Amsterdam, NetherlandsAmsterdam UMC
Oct 17, 2023
Cervical Cancer, Stage IIB Trial in Mexico City (Placebo dairy beverage)
Completed
- Cervical Cancer, Stage IIB
- Placebo dairy beverage
-
Mexico City, Tlalpan, MexicoNational Cancer Institute of Mexico
Feb 16, 2023
Magnetic Resonance Fingerprinting for Preoperative Evaluation of
Recruiting
- Cervical Cancer
-
Roma, ItalyFondazione Policlinico Universitaro "A. Gemelli" IRCCS
Mar 29, 2023
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +6 more
- Atezolizumab
- +2 more
-
Los Angeles, California
- +21 more
Apr 20, 2021
Cervical Cancer Trial in Guangzhou (Type B resection or type C resection of the anterior leaf of vesicouterine ligament during
Recruiting
- Cervical Cancer
- Type B resection or type C resection of the anterior leaf of vesicouterine ligament during the radical hysterectomy (type C)
-
Guangzhou, Guangdong, ChinaHuaiwu Lu
Jun 14, 2023
Activating ALK Gene Mutation Negative, Activating EGFR Gene Mutation Negative, Activating ROS1 Gene Mutation Negative Trial in
Completed
- Activating ALK Gene Mutation Negative
- +7 more
- Counseling
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +8 more
- Cisplatin
- +4 more
-
Los Angeles, California
- +15 more
Sep 1, 2020
Chemotherapy Alone in Poor-differentiated Early-stage Cervical
Recruiting
- Cervical Cancer
-
Guangzhou, Guangdong, ChinaThe Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit
May 16, 2023
Cervical Cancer, Prevention Trial in Ramotswa (Automated visual evaluation)
Active, not recruiting
- Cervical Cancer
- Prevention
- Automated visual evaluation
-
Ramotswa, BotswanaBamalete Lutheran Hospital
Feb 1, 2023
Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)
Not yet recruiting
- Unresectable Lung Non-Small Cell Carcinoma
- serplulimab plus chemotherapy as conversion treatment
- (no location specified)
Apr 27, 2023
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)
Recruiting
- Nasopharyngeal Carcinoma
- mobile platform or not mobile platform
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023
Cervical Cancer Trial in Nanning (tislelizumab, concurrent chemoradiotherapy)
Not yet recruiting
- Cervical Cancer
- tislelizumab
- concurrent chemoradiotherapy
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 22, 2022
Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +10 more
- Discussion
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Cervical Cancer Trial in Shanghai (adjuvant concurrent chemoradiotherapy, radiotherapy)
Recruiting
- Cervical Cancer
- adjuvant concurrent chemoradiotherapy
- radiotherapy
-
Shanghai, Shanghai, China
- +1 more
Sep 14, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +66 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +76 more
Jan 11, 2023
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Cervical Cancer, Stage IIB Trial (Curcumin, Placebo oral tablet)
Withdrawn
- Cervical Cancer, Stage IIB
- Curcumin
- Placebo oral tablet
- (no location specified)
Dec 5, 2022
Cervical Cancer Trial in Chongqing (Lymph node dissection, Standard chemoradiation, Chemoradiation)
Recruiting
- Cervical Cancer
- Lymph node dissection
- +2 more
-
Chongqing, Chongqing, ChinaChongqing Cancer Hospital
Mar 29, 2022